Biocept, Inc.

NasdaqCM:BIOC Stock Report

Market Cap: US$2.7m

Biocept Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BIOC?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders790.00301%
Private Companies5,4930.209%
Institutions218,8048.33%
General Public2,401,65091.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 365.5%.

Top Shareholders

Top 22 shareholders own 8.54% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.15%
The Lind Partners, LLC
135,294US$138.0k0%0.29%
1.71%
Anson Group
44,861US$45.8k0%0.01%
0.9%
Boothbay Fund Management, LLC
23,529US$24.0k0%no data
0.21%
Tower Research Capital LLC
5,389US$5.5k1,840%no data
0.2%
BlackRock, Inc.
5,261US$5.4k-0.04%no data
0.17%
Geode Capital Management, LLC
4,470US$4.6k0%no data
0.17%
The Vanguard Group, Inc.
4,434US$4.5k0%no data
0.01%
Group One Trading LP, Asset Management Arm
270US$275.41.5%no data
0.01%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
268US$273.50%no data
0.0094%
Acadian Asset Management LLC
247US$252.1-46.5%no data
0.0044%
City National Rochdale, LLC
115US$117.3-0.86%no data
0.004%
Hale BioPharma Ventures LLC
104US$106.10%no data
0.0013%
Securities America Advisors, Inc.
33US$33.70%no data
0.0011%
David Hale
30US$30.50%no data
0.00072%
Michael Dugan
19US$19.30%no data
0.00069%
U.S. Bancorp Asset Management, Inc.
18US$18.5-5.26%no data
0.00057%
Bruce Gerhardt
15US$15.30%no data
0.00038%
Timothy Kennedy
10US$10.20%no data
0.00015%
Wells Fargo & Company, Private Banking and Investment Banking Arm
4US$4.033.3%no data
0.00008%
Ivor Royston
2US$2.10%no data
0.00008%
M. Wilson
2US$2.10%no data
0.00004%
Marsha Chandler
1US$1.10%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/10/15 21:46
End of Day Share Price 2023/10/13 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biocept, Inc. is covered by 10 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raghuram SelvarajuAegis Capital Corporation
Sally YanchusBrookline Capital Markets
Kumaraguru RajaBrookline Capital Markets